Literature DB >> 11437925

Distribution of HPV 53, HPV 73 and CP8304 in genital epithelial lesions with different grades of dysplasia.

T Meyer1, R Arndt, E R Beckmann, B Padberg, E Christophers, E Stockfleth.   

Abstract

To characterize the risk of malignant progression of cervical epithelial lesions associated with human papillomavirus (HPV) types of yet unknown oncogenic potential the prevalences of these HPVs in different cervical epithelial lesions of 809 patients were determined. HPV types 53, 73, and CP8304 were detected in genital specimens of 16, 22, and 12 of the patients, respectively. The ratio of prevalence in high grade dysplastic lesions or cancers and low grade dysplastic lesions or normal specimens was calculated and compared to corresponding values of well known high-risk (HR) and low-risk (LR) HPVs. For HPV 6, 11, 16, 18, 35, and 73 a ratio of 0.1, 0.2, 5.9, 6.5, 2.5, and 2.4, respectively, was calculated. The ratios of HPV53 and CP8304 were less than 1. Moreover, in contrast to HPV73, these viruses have never been detected in cancer specimens. Thus, HPV53 and CP8304 infections are probably not associated with a high risk of carcinogenesis, while HPV73 could be another HR-HPV type.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11437925     DOI: 10.1046/j.1525-1438.2001.01009.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  6 in total

1.  HPV73 a nonvaccine type causes cervical cancer.

Authors:  Sergio M Amaro-Filho; Ana Gradissimo; Mykhaylo Usyk; Fabio C B Moreira; Liz M de Almeida; Miguel A M Moreira; Robert D Burk
Journal:  Int J Cancer       Date:  2019-04-29       Impact factor: 7.396

2.  Genetic variability of human papillomavirus type 66 L1 gene among women presenting for cervical cancer screening in Chile.

Authors:  Monserrat Balanda; Jorge Fernández; Nicolás Vergara; Constanza Campano; Loredana Arata; Héctor San Martín; Eugenio Ramírez
Journal:  Med Microbiol Immunol       Date:  2019-06-04       Impact factor: 3.402

3.  Distribution of Human Papillomavirus Genotypes in Liquid-based Samples; Abundance of HPV-53 in Tehran, Iran.

Authors:  Mohammad Pouryasin; Heidar Sharafi; Azam-Sadat Mousavi; Shakiba Khodadad; Mahtab Marjani; Fereshteh Jamshidi; Ali Pouryasin
Journal:  Iran J Public Health       Date:  2014-08       Impact factor: 1.429

4.  Human papillomavirus prevalence and type-distribution among women in Zhejiang Province, Southeast China: a cross-sectional study.

Authors:  Xiao-Xiang Liu; Xing-Li Fan; Yue-Ping Yu; Lei Ji; Jie Yan; Ai-Hua Sun
Journal:  BMC Infect Dis       Date:  2014-12-19       Impact factor: 3.090

5.  Predictors of abnormal cytology among HPV-infected women in remote territories of French Guiana.

Authors:  Antoine Adenis; Valentin Dufit; Maylis Douine; Jerome Ponty; Laure Bianco; Fatiha Najioullah; Odile Kilié; Dominique Catherine; Nadia Thomas; Jean Luc Deshayes; Paul Brousse; Gabriel Carles; Claire Grenier; Vincent Lacoste; Vincent Molinie; Raymond Cesaire; Mathieu Nacher
Journal:  BMC Womens Health       Date:  2018-01-24       Impact factor: 2.809

6.  Uncommon and rare human papillomavirus genotypes relating to cervical carcinomas.

Authors:  Na Rae Kim; Myunghee Kang; Soon Pyo Lee; Hyunchul Kim; Jungsuk An; Dong Hae Chung; Seung Yeon Ha; Hyun Yee Cho
Journal:  Korean J Pathol       Date:  2014-02-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.